Medicare utilization — LESLIE CRUZ (FNP-BC)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 535 | 107 | $0 | $185 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 368 | 86 | $0 | $267 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 328 | 246 | $0 | $25,281 |
| 96372 | Injection of drug or substance under skin or into muscle | 267 | 169 | $0 | $2,068 |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | 177 | 154 | $0 | $9,870 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·